Literature DB >> 17021118

In vitro activities of daptomycin, ciprofloxacin, and other antimicrobial agents against the cells and spores of clinical isolates of Bacillus species.

Diane M Citron1, Maria D Appleman.   

Abstract

Daptomycin inhibited 67 of 70 clinical isolates of Bacillus species at < or =1 microg/ml and 100% of them at < or =2 microg/ml. It showed bactericidal activity similar to that of ciprofloxacin against vegetative cells but not against spores. For 2 strains, the ciprofloxacin MICs were >4 g/ml, and 10 strains were resistant to erythromycin.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17021118      PMCID： PMC1594774          DOI： 10.1128/JCM.00881-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

Review 1.  Meningoencephalitis caused by Bacillus cereus in a neonate.

Authors:  W P Chu; T L Que; W K Lee; S N Wong
Journal:  Hong Kong Med J       Date:  2001-03       Impact factor: 2.227

2.  Susceptibility testing of Bacillus species.

Authors:  J M Andrews; R Wise
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

Review 3.  Epidemiology and pathogenesis of Bacillus cereus infections.

Authors:  A Kotiranta; K Lounatmaa; M Haapasalo
Journal:  Microbes Infect       Date:  2000-02       Impact factor: 2.700

4.  Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods.

Authors:  M Jasmine Mohammed; Chung K Marston; Tanja Popovic; Robbin S Weyant; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 5.  Bacillus cereus bacteremia and meningitis in immunocompromised children.

Authors:  A H Gaur; C C Patrick; J A McCullers; P M Flynn; T A Pearson; B I Razzouk; S J Thompson; J L Shenep
Journal:  Clin Infect Dis       Date:  2001-04-20       Impact factor: 9.079

6.  Antimicrobial susceptibilities of diverse Bacillus anthracis isolates.

Authors:  Pamala R Coker; Kimothy L Smith; Martin E Hugh-Jones
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

7.  Daptomycin morphostructural damage in Bacillus cereus visualized by atomic force microscopy.

Authors:  P C Braga; D Ricci; M Dal Sasso
Journal:  J Chemother       Date:  2002-08       Impact factor: 1.714

Review 8.  Bacillus sphaericus bacteraemia in children with cancer: case reports and literature review.

Authors:  E Castagnola; F Fioredda; M A Barretta; L Pescetto; A Garaventa; E Lanino; C Micalizzi; R Giacchino; G Dini
Journal:  J Hosp Infect       Date:  2001-06       Impact factor: 3.926

Review 9.  Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Authors:  Judith N Steenbergen; Jeff Alder; Grace M Thorne; Francis P Tally
Journal:  J Antimicrob Chemother       Date:  2005-02-10       Impact factor: 5.790

Review 10.  Bacillus cereus bacteremia in a preterm neonate.

Authors:  Nicholaus J Hilliard; Robert L Schelonka; Ken B Waites
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948
View more
  14 in total

1.  Elucidating the Catalytic Power of Glutamate Racemase by Investigating a Series of Covalent Inhibitors.

Authors:  Nicholas R Vance; Katie R Witkin; Patrick W Rooney; Yalan Li; Marshall Pope; M Ashley Spies
Journal:  ChemMedChem       Date:  2018-11-21       Impact factor: 3.466

Review 2.  Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature.

Authors:  Romain Lotte; Alicia Chevalier; Laurent Boyer; Raymond Ruimy
Journal:  Clin Microbiol Rev       Date:  2022-02-09       Impact factor: 50.129

3.  Development of a novel heterologous β-lactam-specific whole-cell biosensor in Bacillus subtilis.

Authors:  Nina Lautenschläger; Philipp F Popp; Thorsten Mascher
Journal:  J Biol Eng       Date:  2020-07-31       Impact factor: 4.355

Review 4.  A current perspective on daptomycin for the clinical microbiologist.

Authors:  Romney M Humphries; Simon Pollett; George Sakoulas
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

5.  Daptomycin exerts rapid bactericidal activity against Bacillus anthracis without disrupting membrane integrity.

Authors:  Yu-hua Xing; Wei Wang; Su-qin Dai; Ti-yan Liu; Jun-jie Tan; Guo-long Qu; Yu-xia Li; Yan Ling; Gang Liu; Xue-qi Fu; Hui-peng Chen
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150

6.  Clinical characteristics and antimicrobial susceptibility of Bacillus cereus blood stream infections.

Authors:  Mahoko Ikeda; Yuka Yagihara; Keita Tatsuno; Mitsuhiro Okazaki; Shu Okugawa; Kyoji Moriya
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-09-15       Impact factor: 3.944

7.  Automated ribotyping and antibiotic resistance determining of Bacillus spp from conjunctiva of diabetic patients.

Authors:  Sertaç Argun Kıvanç; Merih Kıvanç; Gülay Güllülü
Journal:  Iran J Basic Med Sci       Date:  2014-02       Impact factor: 2.699

8.  Persistent Bacillus cereus Bacteremia in 3 Persons Who Inject Drugs, San Diego, California, USA.

Authors:  Gabrielle Schaefer; Wesley Campbell; Jeffrey Jenks; Cari Beesley; Theodoros Katsivas; Alex Hoffmaster; Sanjay R Mehta; Sharon Reed
Journal:  Emerg Infect Dis       Date:  2016-09       Impact factor: 6.883

9.  Chromosome Segregation in Bacillus subtilis Follows an Overall Pattern of Linear Movement and Is Highly Robust against Cell Cycle Perturbations.

Authors:  Nina El Najjar; David Geisel; Felix Schmidt; Simon Dersch; Benjamin Mayer; Raimo Hartmann; Bruno Eckhardt; Peter Lenz; Peter L Graumann
Journal:  mSphere       Date:  2020-06-17       Impact factor: 4.389

10.  Antibiotics resistance and toxin profiles of Bacillus cereus-group isolates from fresh vegetables from German retail markets.

Authors:  Gregor Fiedler; Carmen Schneider; Etinosa O Igbinosa; Jan Kabisch; Erik Brinks; Biserka Becker; Dominic A Stoll; Gyu-Sung Cho; Melanie Huch; Charles M A P Franz
Journal:  BMC Microbiol       Date:  2019-11-09       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.